Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access April 8, 2011

Epicardial adipose tissue and relationship with coronary artery disease

  • Alina Silaghi EMAIL logo , Raluca Pais , Ana Valea , Aurel Mironiuc and Horatiu Silaghi
From the journal Open Medicine


Epicardial adipose tissue (EAT) is metabolically active tissue that accumulates around the coronary arteries. Epicardial fat is a rich source of free fatty acids and may contribute to local inflammatory load by increased synthesis of inflammatory cytokines. Direct passage of bioactive molecules into the coronary arteries due to close contact with the vascular wall and the lack of fascia may contribute to the pathogenesis of coronary artery disease. Direct correlation between visceral fat and EAT defines the latter as an indirect marker of intra-abdominal visceral adiposity. EAT is related to anthropometric and clinical features of the metabolic syndrome (MS) and to hepatic transaminases as markers of steatohepatitis. An increase in EAT thickness is related to an increase in left ventricular mass and is correlated with atrial enlargement and impairment in diastolic filling in obesity. Echocardiographic study of EAT is an easy and reliable imaging indicator of visceral adiposity and cardiovascular risk. EAT is an independent factor strongly correlated with significant coronary stenosis. A level of EAT above an established average value can be considered a predictive marker of cardiovascular risk. We review the most recent studies proving the specific active role of EAT in the development of cardiac disease.

[1] Vague J., La différenciation sexuelle, facteur déterminant des formes de l’obésité, Presse Med., 1947, 55, 339–340 Search in Google Scholar

[2] Bjorntrop P., Metabolic implications of body fat distribution, Diabetes Care, 1991, 14, 1132–1143 in Google Scholar

[3] Ravussin E., Smith S.R., Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus, Ann N Y Acad Sci, 2002 Jun, 967, 363–378 in Google Scholar

[4] Rabkin S.W., Epicardial fat: properties, function and relationship to obesity, Obes Rev, 2007 May, 8, 253–261 10.1111/j.1467-789X.2006.00293.xSearch in Google Scholar

[5] Marchington J.M., Mattacks C.A., Pond C.M., Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties, Comp Biochem Physiol, 1989, 94, 225–232 10.1016/0305-0491(89)90337-4Search in Google Scholar

[6] Stern N., Marcus Y., Perivascular fat: innocent bystander or active player in vascular disease?, J Cardiometab Syndr, 2006, Spring, 1, 115–120 in Google Scholar PubMed

[7] Willens H.J., Gómez-Marín O., Comparison of epicardial and pericardial fat thickness assessed by echocardiography in African American and non-Hispanic White men: a pilot study, Ethn Dis, 2008, Summer, 18, 311–316 Search in Google Scholar

[8] Reiner L., Mazzoleni A., Rodriguez F.l., Statistical analysis of the epicardial fat weight in human hearts, AMA Arch Pathol, 1955 Oct, 60, 369–373 Search in Google Scholar

[9] Corradi D., Maestri R., Callegari S., Pastori P., Goldoni M., Luong T.V., et al., The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts, Cardiovasc Pathol, 2004, 13, 313–316 in Google Scholar PubMed

[10] Iacobellis G., Assael F., Ribaudo M.C., Zappaterreno A., Alessi G., Di Mario U.,et al., Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction, Obes Res, 2003, 11, 304–310 in Google Scholar PubMed

[11] Silaghi A., Piercecchi-Marti M.D., Grino M., Leonetti G., Alessi M.C., Clement K., et al., Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy, Obesity, 2008, 16, 2424–2430 in Google Scholar PubMed

[12] Shimokawa H., Ito A., Fukumoto Y., Kadokami T., Nakaike R., Sakata M., et al., Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor, J Clin Invest, 1996, 97, 769–776 in Google Scholar PubMed PubMed Central

[13] Miyata K., Shimokawa H., Kandabashi T., Higo T., Morishige K., Eto Y., et al., Rho-kinase is involved in macrophagemediated formation of coronary vascular lesions in pigs in vivo, Arterioscler Thromb Vasc Biol, 2000, Nov, 20, 2351–2358 10.1161/01.ATV.20.11.2351Search in Google Scholar

[14] Ishii T., Asuwa N., Masuda S., Ishikawa Y., The effects of a myocardial bridge on coronary atherosclerosis and ischaemia, J Pathol, 1998, May 185, 4–9<4::AID-PATH50>3.0.CO;2-310.1002/(SICI)1096-9896(199805)185:1<4::AID-PATH50>3.0.CO;2-3Search in Google Scholar

[15] Ishikawa Y., Ishii T., Asuwa N., Masuda S., Absence of atherosclerosis evolution in the coronary arterial segment covered by myocardial tissue in cholesterol-fed rabbits, Virchows Arch, 1997, Feb 430, 163–171 in Google Scholar

[16] Henrichot E., Juge-Aubry C.E., Pernin A., Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?, Arterioscler Thromb Vasc Biol, 2005, Dec, 25, 2594–2599 in Google Scholar

[17] Mazurek T., Zhang L., Zalewski A., Mannion J.D., Diehl J.T., Arafat H.,et al., Human epicardial adipose tissue is a source of inflammatory mediators, Circulation, 2003,18;108(20), 2460–2466 in Google Scholar

[18] Karastergiou K., Evans I., Ogston N., Miheisi N., Nair D., Kaski JC., et al., Epicardial adipokines in obesity and coronary artery disease induce atherogenic changes in monocytes and endothelial cells, Arterioscler Thromb Vasc Biol, 2010, 30, 1340–1346 in Google Scholar

[19] Iacobellis G., Pistilli D., Gucciardo M., Leonetti F., Miraldi F., Brancaccio G., et al., Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease, Cytokine, 2005, 21,29, 251–255 10.1016/j.cyto.2004.11.002Search in Google Scholar

[20] Iglesias M.J., Eiras S., Piñeiro R., López-Otero D., Gallego R., Fernández A.L., et al., Gender differences in adiponectin and leptin expression in epicardial and subcutaneous adipose tissue, Findings in patients undergoing cardiac surgery, Rev Esp Cardiol, 2006, 59, 1252–1260 in Google Scholar

[21] Kourliouros A., Karastergiou K., Nowell J., Gukop P., Tavakkoli Hosseini M., et al., Protective effect of epicardial adiponectin on atrial fibrillation following cardiac surgery. Eur J Cardiothorac Surg, 2010, Jul 5, in press, DOI:10.1016/j.ejcts.2010.05.006 10.1016/j.ejcts.2010.05.006Search in Google Scholar

[22] Baker A.R., Silva N.F., Quinn D.W., Harte A.L., Pagano D., Bonser R.S., et al., Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease, Cardiovasc, Diabetol, 2006, 5, 1–7 in Google Scholar

[23] Fain J.N., Sacks H.S., Buehrer B., Bahouth S.W., Garrett E., Wolf R.Y., et al., Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots, Int J Obes (Lond), 2008, 32, 810–815 in Google Scholar

[24] Malavazos A.E., Ermetici F., Cereda E., Ambrosi B., Epicardial fat thickness: relationshipwith plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity, Nutr Metab Cardiovasc Dis, 2008, 18, 523–530 in Google Scholar PubMed

[25] Roubícek T., Dolinková M., Bláha J., Haluzíková D., Bosanská L., Mráz M., et al., Increased angiotensinogen production in epicardial adipose tissue during cardiac surgery: possible role in a postoperative insulin resistance, Physiol Res, 2008, 57, 911–917 10.33549/physiolres.931315Search in Google Scholar PubMed

[26] Ferder L., Inserra F., Martínez-Maldonado M., Inflammation and the metabolic syndrome: role of angiotensin II and oxidative stress, Curr Hypertens Rep, 2006, 8, 191–198 in Google Scholar PubMed

[27] Kurata A., Nishizawa H., Kihara S., Maeda N., Sonoda M., Okada T., et al. Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation, Kidney Int, 2006, 70, 1717–1724 in Google Scholar PubMed

[28] Hamid S.A., Baxter G.F., Adrenomedullin: regulator of systemic and cardiac homeostasis in acute myocardial infarction, Pharmacol Therapeut, 2005, 105, 95–112 in Google Scholar PubMed

[29] Ishimitsu T., Ono H., Minami J., Matsuoka H., Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders, Pharmacol Therapeut, 2006, 111, 909–927 in Google Scholar PubMed

[30] Hamid S.A., Baxter G.F., A critical cytoprotective role of endogenous adrenomedullin in acute myocardial infarction, J Mol Cell Cardiol, 2006, 41, 360–363 in Google Scholar PubMed

[31] Silaghi A., Achard V., Paulmyer-Lacroix O., Scridon T., Tassistro V., Duncea I., et al., Expression of adrenomedullin in human epicardial adipose tissue: role of coronary status. Am J Physiol Endocrinol Metab, 2007, 293, E1443–E1450 in Google Scholar PubMed

[32] Marchington J.M., Pond C.M., Site specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro, Int J Obes, 1990, 14, 1013–1022 Search in Google Scholar

[33] Vural B., Atalar F., Ciftci C., Demirkan A., Susleyici-Duman B., Gunay D., et al., Presence of fatty-acidbinding protein 4 expression in human epicardial adipose tissue in metabolic syndrome, Cardiovasc Pathol, 2008, 17, 392–398 in Google Scholar PubMed

[34] Pond C.M., The contribution of wild animal biology to human physiology and medicine: adipose tissue associated with lymphoid and cardiac tissues, Ecoscience, 2003, 10, 1–9 Search in Google Scholar

[35] Salgado-Somoza A., Teijeira-Fernández E., Fernández A.L., González-Juanatey J.R., Eiras S., Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress, Am J Physiol Heart Circ Physiol, 2010, 299, H202–H209 in Google Scholar PubMed

[36] Iacobellis G., Leonetti F., Epicardial adipose tissue and insulin resistance in obese Subjects, J Clin Endocrinol Metab, 2005, 90, 6300–6302 in Google Scholar PubMed

[37] Sacks H.S., Fain J.N., Human epicardial adipose tissue: a review, Am Heart J, 2007 Jun, 153, 907–917 in Google Scholar PubMed

[38] Iacobellis G., Ribaudo M.C., Assael F., Vecci E., Tiberti C., Zappaterreno A., et al., Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk, J Clin Endocrinol Metab, 2003, 88, 5163–5168 in Google Scholar PubMed

[39] Singh N., Singh H., Khanijoun HK., Iacobellis G., Echocardiographic assessment of epicardial adipose tissue — a marker of visceral adiposity, Mcgill J Med, 2007, 10, 26–30 10.26443/mjm.v10i1.469Search in Google Scholar

[40] Iacobellis G., Corradi D., Sharma AM., Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart, Nat Clin Pract Cardiovasc Med, 2005, 2, 536–543 in Google Scholar PubMed

[41] Ahn S.G., Lim H.S., Joe D.Y., Kang S.J., Choi B.J., Choi S.Y., et al., Relationship of Epicardial Adipose Tissue by Echocardiography to Coronary Artery Disease, Relationship of epicardial adipose tissue by echocardiography to coronary artery disease, Heart, 2008, 94, e7 in Google Scholar PubMed

[42] Iacobellis G., Singh N., Wharton S., Sharma A.M., Substantial changes in epicardial fat thickness after weight loss in severely obese subjects, Obesity (Silver Spring), 2008, 16, 1693–1697 in Google Scholar PubMed

[43] Willens H.J., Byers P., Chirinos J.A., Labrador E., Hare J.M., de Marchena E., et al., Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography, Am J Cardiol, 2007, 1, 99, 1242–1245 in Google Scholar PubMed

[44] Iacobellis G., Sharma AM., Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome, Curr Pharm Des, 2007, 13, 2180–2184 in Google Scholar PubMed

[45] Iacobellis G., Imaging of visceral adipose tissue: an emerging diagnostic tool and therapeutic target, Curr Drug Targets Cardiovasc Haematol Disord, 2005, 5, 345–353 in Google Scholar PubMed

[46] Gorter P.M., van Lindert A.S., de Vos A.M., Meijs M.F., van der Graaf Y., Doevendans P.A., et al., Quantification of epicardial and pericoronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease, Atherosclerosis, 2008, 197, 896–903 in Google Scholar PubMed

[47] Flüchter., Haghi D., Dinter D., Heberlein W., Kühl H.P., Neff W., et al., Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging, Obesity (Silver Spring), 2007, 15, 870–878 in Google Scholar PubMed

[48] Kessels K., Cramer M.J., Velthuis B., Epicardial adipose tissue imaged by magnetic resonance imaging: an important risk marker of cardiovascular disease, Heart, 2006, 92, 962 in Google Scholar PubMed PubMed Central

[49] Sarin S., Wenger C., Marwaha A., Qureshi A., Go B.D., Woomert C.A., et al., Clinical significance of epicardial fat measured using cardiac multislice computed tomography, Am J Cardiol, 2008, Sep 15, 102, 767–771 in Google Scholar PubMed

[50] Bastarrika G., Broncano J., Schoepf UJ., Schwarz F., Lee YS., Abro JA., et al., Relationship between coronary artery disease and epicardial adipose tissue quantification at cardiac CT: comparison between automatic volumetric measurement and manual bidimensional estimation, Acad Radiol, 2010, 17, 727–734 in Google Scholar PubMed

[51] Kankaanpää M., Lehto H.R., Pärkkä J.P., Komu M., Viljanen A., Ferrannini E., et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels, J Clin Endocrinol Metab, 2006, 91, 4689–4695 in Google Scholar PubMed

[52] Vasan R.S., Cardiac function and obesity, Heart, 2003, 89, 1127–1129 in Google Scholar PubMed PubMed Central

[53] Pascual M., Pascual D.A., Soria F., Effects of isolated obesity on systolic and diastolic left ventricular function, Heart, 2003, 89, 1152–1156 in Google Scholar PubMed PubMed Central

[54] Peterson L.R., Waggoner A.D., Schechtman K.B., Meyer T., Gropler R.J., Barzilai B., et al., Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging, J Am Coll Cardiol, 2004, 43, 1399–1404 in Google Scholar PubMed

[55] Otto M.E., Belohlavek M., Romero-Corral A., Gami A.S., Gilman G., Svatikova A., et al. Comparison of right and left ventricular function in obese and nonobese men, Am J Cardiol, 2004, 93, 1569–1572 in Google Scholar PubMed

[56] Krishnan R., Becker R.J., Beighley L.M., Lopez-Candales A., Impact of body mass index on markers of left ventricular thickness and mass calculation: results of a pilot analysis, Echocardiography, 2005, 22, 203–210 in Google Scholar PubMed

[57] Iacobellis G., Ribaudo MC., Zappaterreno A., Iannucci C.V., Leonetti F., et al., Prevalence of uncomplicated obesity in an Italian obese population, Obes Res, 2005, 13, 1116–122 in Google Scholar PubMed

[58] Iacobellis G., Ribaudo M.C., Leto G., Zappaterreno A., Vecci E., Di Mario U., et al., Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity, Obes Res, 2002, 10, 767–773 in Google Scholar PubMed

[59] Iacobellis G., True uncomplicated obesity is not related to increased left ventricular mass and systolic dysfunction, J Am Coll Cardiol, 2004, 44, 2257 in Google Scholar PubMed

[60] Iacobellis G., Ribaudo MC., Zappaterreno A., Iannucci C.V., Di Mario U., Leonetti F., et al., Adapted changes in left ventricular structure and function in severe uncomplicated obesity, Obes Res, 2004, 12, 1616–1621 in Google Scholar PubMed

[61] Iacobellis G., Ribaudo MC., Zappaterreno A., Iannucci C.V., Leonetti F., et al., Relation between epicardial adipose tissue and left ventricular mass, Am J Cardiol, 2004, 94, 1084–1087 in Google Scholar PubMed

[62] Gates P.E., Gentile C.L., Seals D.R., Christou D.D., Adiposity contributes to differences in left ventricular structure and diastolic function with age in healthy men, J Clin Endocrinol Metab, 2003, 88, 4884–4890 in Google Scholar PubMed

[63] Mureddu G.F., Greco R., Rosato G.F., Cella A., Vaccaro O., Contaldo F., et al. Relation of insulin resistance to left ventricular hypertrophy and diastolic dysfunction in obesity, Int J Obes Relat Metab Disord, 1998, 22, 363–368 in Google Scholar PubMed

[64] Iacobellis G., Leonetti F., Singh N., M Sharma A., Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. Int J Cardiol, 2007, 115, 272–273 in Google Scholar PubMed

[65] Kazlauskaite R., Doukky R., Evans A., Margeta B., Ruchi A., Fogelfeld L., et al., Predictors of diastolic dysfunction among minority patients with newly diagnosed type 2 diabetes, Diabetes Res Clin Pract, 2010, 88, 189–195 in Google Scholar PubMed PubMed Central

[66] Iacobellis G., Pellicelli A.M., Grisorio B., Barbarini G., Leonetti F., Sharma A.M., et al., Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat, Obesity (Silver Spring), 2008, 16, 179–183 in Google Scholar

[67] Cikim A.S., Topal E., Harputluoglu M., Keskin L., Zengin Z., Cikim K., et al. Epicardial adipose tissue, hepatic steatosis and obesity, J Endocrinol Invest, 2007, 30, 459–464 10.1007/BF03346328Search in Google Scholar

[68] Stramaglia G., Greco A., Guglielmi G., De Matthaeis A., Vendemiale GL., Echocardiography and dual-energy x-ray absorptiometry in the elderly patients with metabolic syndrome: a comparison of two different tecniques to evaluate visceral fat distribution, J Nutr Health Aging, 2010, 14, 6–10 in Google Scholar

[69] Perseghin G., Lattuada G., De Cobelli F., Esposito A., Belloni E., Ntali G., et al., Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver, Hepatology, 2008, 47, 51–58 in Google Scholar

[70] Prati F., Arbustini E., Labellarte A., Sommariva L., Pawlowski T., Manzoli A., et al., Eccentric atherosclerotic plaques with positive remodelling have a pericardial distribution: a permissive role of epicardial fat? A threedimensional intravascular ultrasound study of left anterior descending artery lesions, Eur Heart J, 2003, 24, 329–336 in Google Scholar

[71] Iacobellis G., Gao YJ., Sharma AM., Do cardiac and perivascular adipose tissue play a role in atherosclerosis?, Curr Diab Rep, 2008, 8, 20–24 in Google Scholar PubMed

[72] Jeong J.W., Jeong M.H., Yun K.H., Oh S.K., Park E.M., Kim Y.K., et al., Echocardiographic epicardial fat thickness and coronary artery disease, Circ J, 2007, 71, 536–539 in Google Scholar PubMed

[73] Chaowalit N., Somers V.K., Pellikka P.A, Rihal C.S., Lopez-Jimenez F., et al., Subepicardial adipose tissue and the presence and severity of coronary artery disease, Atherosclerosis, 2006, 186, 354–359 in Google Scholar PubMed

[74] Chaowalit N., Lopez-Jimenez F., Epicardial adipose tissue: friendly companion or hazardous neighbour for adjacent coronary arteries?, Eur Heart J., 2008, 29, 695–697 in Google Scholar PubMed

[75] Gorter P.M., de Vos A.M., van der Graaf Y., Stella P.R., Doevendans P.A., Meijs M.F., et al., Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography, Am J Cardiol, 2008, 102, 380–385 in Google Scholar PubMed

[76] Iacobellis G., Willens H.J., Barbaro G., Sharma A.M., Threshold Values of High-risk Echocardiographic Epicardial Fat Thickness, Obesity (Silver Spring), 2008, 16, 887–892 in Google Scholar PubMed

[77] Iacobellis G., Pellicelli AM., Sharma AM., Grisorio B., Barbarini G., Barbaro G., Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus. Am J Cardiol, 2007, 99, 1470–1472 in Google Scholar PubMed

[78] Iacobellis G., Sharma A.M., Pellicelli A.M, Grisorio B., Barbarini G., Barbaro G., et al., Epicardial adipose tissue is related to carotid intima-media thickness and visceral adiposity in HIV-infected patients with highly active antiretroviral therapy-associated metabolic syndrome, Curr HIV Res, 2007, 5, 275–279 in Google Scholar PubMed

[79] Lanes R., Soros A., Flores K., Gunczler P., Carrillo E., Bandel J., et al., Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: apparent effects of growth hormone treatment on these parameters, J Clin Endocrinol Metab, 2005, 90, 3978–3982 in Google Scholar PubMed

Published Online: 2011-4-8
Published in Print: 2011-6-1

© 2011 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 23.9.2023 from
Scroll to top button